The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a new study.

Source: HIV drug shows efficacy in treating mouse models of HER2+ breast cancer, study suggests


David Cottle

UBB Owner & Administrator